170842 ⎘
Detection or diagnosis of diseases; Neurological disorders; Dementia; Cognitive disorders Alzheimer
NOVEL COMPOUNDS FOR DIAGNOSIS
#302RGO-BASED BIOSENSOR, MANUFACTURING METHOD OF SAME, AND DETECTION METHOD FOR BIOMATERIAL
#303METHOD FOR OBTAINING INFORMATION ON COGNITIVE FUNCTION, METHOD FOR DETERMINING EFFECTIVENESS OF MEDICAL INTERVENTION ABOUT COGNITIVE FUNCTION
#304METHOD FOR THE DETECTION OF APOLIPOPROTEIN E4
#305Blood biomarker for discerning beta amyloid accumulation in brain
#306Antibodies specific for hyperphosphorylated tau and methods of use thereof
#307Antibody-based molecules specific for the truncated ASP421 epitope of Tau and their uses in the diagnosis and treatment of tauopathy
#308Catabodies and methods of use thereof
#309Composition for detecting hydrogen sulfide or measuring hydrogen sulfide concentration and composition comprising same as effective ingredient for diagnosing or imaging in vivo inflammation, tissues having hypoxic damage, or cancer
#310DENDRITIC CELL RECRUITMENT FROM BLOOD TO BRAIN IN NEURODEGENERATIVE DISEASE
#311Anti-PHF-tau antibodies and uses thereof
#312PEPTIDE ANALYZING METHOD
#313ANTIBODY THAT SPECIFICALLY RECOGNIZES N TERMINUS OF APP669-x, AND IMMUNOASSAY METHOD
#314DISEASE RISK ASSESSMENT APPARATUS, DISEASE RISK ASSESSMENT METHOD, COMPUTER READABLE MEDIUM, AND FOOD FOR DEMENTIA PREVENTION
#315Methods of binding amyloid beta protein having pyroglutamate at the third amino acid residue (3pE abeta) in vivo using anti-3pE abeta antibodies or antigen-binding fragments thereof
#316SEPTAPEPTIDES ASSOCIATED WITH NEURODEGENERACY
#317Tau-binding antibodies
#318METHODS OF IDENTIFYING AN INDIVIDUAL AS HAVING OR BEING AT RISK OF DEVELOPING AN AMYLOID-POSITIVE DEMENTIA BASED ON MARKER MOLECULES AND RELATED USES
#319FIBROBLAST GROWTH PATTERNS FOR DIAGNOSIS OF ALZHEIMER'S DISEASE
#320Antibodies recognizing tau
#321CERAMIDE MIMICS FOR TREATMENT OF ALZHEIMER'S DISEASE
#322p53 peptides as markers in the diagnosis and prognosis of Alzheimer's disease
#323EXOSOMAL TAU AS A BIOMARKER FOR BRAIN DISORDERS
#324DIAGNOSTIC METHOD FOR MULTIPLE SCLEROSIS
#325Cell-Based Biosensor for Early Alzheimer's Disease Detection
#326DETECTION OF MISFOLDED PROTEINS
#327Quantification of biomarkers present in physiological samples
#328Quantification of biomarkers present in dried physiological samples
#329Method of inhibiting tau phosphorylation
#330Machine learning for amyloid and tau pathology prediction
#331Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide
#332Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide
#333Antibody binding a linear epitope of human P53 and diagnostic applications thereof
#334Methods for the Treatment and Diagnosis of Alzheimer's Disease and Traumatic Brain Injuries
#335Antibody binding a linear epitope of human P53 and diagnostic applications thereof
#336Immunological targeting of pathological tau proteins
#337Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy
#338DIAGNOSTIC COMPOSITIONS FOR PET IMAGING, A METHOD FOR MANUFACTURING THE DIAGNOSTIC COMPOSITION AND ITS USE IN DIAGNOSTICS
#339AZACARBOLINE COMPOUNDS FOR THE DETECTION OF TAU AGGREGATES
#340Compositions comprising cyclic peptides derived from an A-beta peptide
#341Human alzheimer's disease and traumatic brain injury associated tau variants as biomarkers and methods of use thereof
#342METHODS OF DETECTING NEURODEGENERATIVE DISEASE
#343METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES
#344COMPOSITION FOR SCREENING ONGOING PROGRESS OF ALZHEIMER'S DISEASE BY USING BETA AMYLOID OLIGOMER IN NASAL DISCHARGE SPECIMEN AND METHOD FOR SCREENING ONGOING PROGRESS OF ALZHEIMER'S DISEASE BY USING SAME
#345DYES FOR ANALYSIS OF PROTEIN AGGREGATION
#346Humanized tau antibodies in Alzheimer's disease
#347Anti-PHF-tau antibodies and uses thereof
#348DETECTION OF ALZHEIMER'S DISEASE (AD), FRONTOTEMPORAL LOBAR DEGENERATION (FTLD), AMYOTROPHIC LATERAL SCHLEROSIS (ALS), PARKINSON'S DISEASE (PD), AND DEMENTIA WITH LEWY BODIES (DLB) INDICATED BY PHOSPHORYLATION OF MARCKS
#349ASSAYS TO DETECT NEURODEGENERATION
#350METHODS FOR DEVELOPING PHARMACEUTICALS FOR TREATING NEURODEGENERATIVE CONDITIONS
#351Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
#352Nervous system-specific transmembrane proteasome complex that modulates neuronal signaling through extracellular signaling via brain activity peptides
#353APOE MODIFICATIONS AND USES THEREOF
#354APOE PROMOTOR SNP ASSOCIATED WITH RISK OF ALZHEIMER'S DISEASE AND THE USE THEREOF
#355Diagnosing and treating Alzheimer's disease
#356MicroRNA-455-3p as a peripheral biomarker for Alzheimer's disease
#357Methods for evaluating and improving cognitive function
#358SRM methods in Alzheimer's disease and neurological disease assays
#359ASTROCYTE EXOSOME COMPLEMENT-BASED ASSAY FOR NEUROINFLAMMATION IN ALZHEIMER'S DISEASE AND USES THEREOF
#360Early-stage Alzheimer's disease autoantibody biomarkers, target antigens and diagnostic uses thereof
#361Blood cell biomarker for late onset Alzheimer's disease
#362Hyperspectral image-guided ocular imager for alzheimer's disease pathologies
#363Modulation of gene expression in a human bioreactor
#364METHOD FOR QUANTIFYING PROTEIN AGGREGATES OF A PROTEIN MISFOLDING DISEASE IN A SAMPLE
#365Amyloid-beta-binding peptides and the use thereof for the treatment and diagnosis of Alzheimer's disease
#366ANTIBODY ARRAY FOR MEASURING A PANEL OF AMYLOIDS
#367SYNAPTIC PROTEIN BIOMARKERS AND DIFFERENTIAL DIAGNOSIS OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS
#368MIRNAS AS BIOMARKERS FOR ALZHEIMER'S DISEASE
#369Antibody based reagents that specifically recognize toxic oligomeric forms of tau
#370METHOD OF DISTINGUISHING BETWEEN DIFFERENT NEURODEGENERATIVE DISEASES
#371METHOD FOR ACQUIRING INFORMATION ON ANALYTE
#372Josephson toroidal vortex quantum superconductive/memcapacitive and superconductive/memristive devices of making and their applications at room temperature thereto
#373Tau protease compositions and methods of use
#374Nano-theranostics for Parkinson's disease
#375Methods for the detection of tau protein aggregates
#376DARPin reagents that distinguish Alzheimer's disease and Parkinson's disease samples
#377COMPOSITIONS AND METHODS RELATED TO SEX- SPECIFIC METABOLIC DRIVERS IN ALZHEIMERS DISEASE
#378Attenuated total reflectance-based biosensor for conformation and secondary structure analysis
#379Method for the diagnosis and prognosis of neurodegenerative and neuroinflammatory pathologies
#380Biomarkers for cognitive impairment and methods for detecting cognitive impairment using such biomarkers
#381Anti-amyloid-beta antibodies
#382Diagnosing and treating alzheimer's disease
#383Circulating serum microRNA biomarkers and methods for Alzheimer's disease diagnosis
#384Antibodies specific for hyperphosphorylated tau and methods of use thereof
#385Assays to detect neurodegeneration
#386Neuronal viability factor and use thereof in Alzheimer's disease
#387Methods of reducing toxicity induced by Amyloid beta (A-beta) oligomers using antibodies specific to A-beta oligomers
#388BRAIN SPECIFIC EXOSOME BASED DIAGNOSTICS AND EXTRACORPOREAL THERAPIES
#389METHODS FOR DIAGNOSING AND TREATING ALZHEIMER'S DISEASE
#390DIAGNOSIS-AIDING METHOD FOR DETERMINING NEURODEGENERATIVE DISEASE
#391Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
#392Methods of detecting pyroglutamate amyloid beta protein (3pE Aβ) using anti-3pE Aβ antibodies
#393Label-Free Single and Multi-Photon Fluorescence Spectroscopy to Detect Brain Disorders and Diseases: Alzheimer, Parkinson, and Autism From Brain Tissue, Cells, Spinal Fluid, and Body Fluids
#394DIAGNOSTIC MARKERS OF COGNITIVE IMPAIRMENTS, KITS AND USES THEREOF
#395VITRO DIAGNOSTIC METHOD FOR ALZHEIMER'S DISEASE BASED ON THE ALBUMIN REDOX LEVEL IN THE CEREBROSPINAL FLUID
#396Macrocyclic modulators of disease associated protein misfolding and aggregation
#397FKBP52-TAU INTERACTION AS A NOVEL THERAPEUTICAL TARGET FOR TREATING THE NEUROLOGICAL DISORDERS INVOLVING TAU DYSFUNCTION
#398Humanized antibodies
#399RAPID MULTIPLEX DIAGNOSTIC FOR PARKINSON'S DISEASE AND ALZHEIMER'S DISEASE
#400Detection and treatment of neurological diseases
#401COMBINATORIAL SYNTHESIS AND BIOMARKER DEVELOPMENT
#402Biosensor for diagnosing Alzheimer's disease using Rayleigh scattering and colorimetric assay of gold nanoparticle and multi-detection method using the biosensor
#403Tau immunotherapy
#404System for monitoring post-translational modification of protein using bio-sensor with gap and manufacturing method for bio-sensor
#405Antibodies specific for hyperphosphorylated tau and methods of use thereof
#406USE OF PEPTIDES AS BIOMARKERS IN THE DIAGNOSIS, CONFIRMATION AND TREATMENT OF A NEUROLOGICAL DISORDER AND TCR AND/OR HLA IMMUNOPROFILING IN NEURODEGENERATIVE DISEASE
#407Methods of using GM6 in diagnosing and treating Alzheimers disease
#408Methods of diagnosis and treatment of Alzheimer's Disease
#409METHODS OF TREATING DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE WITH PROTECTIVE PROTEIN/CATHEPSIN A (PPCA)
#410ANTIBODY BASED REAGENTS THAT SPECIFICALLY RECOGNIZE TOXIC OLIGOMERIC FORMS OF TAU
#411IDENTIFICATION OF SIGNATURES FOR NEURODEGENERATION DISEASES DIAGNOSES
#412HUMANIZED ANTIBODY
#413Methods for in vitro investigating mitochondrial replication dysfunction in a biological sample, kits and uses thereof, therapeutic methods against progeroid-like syndromes or symptoms and screening method for identifying particular protease inhibitor(s) and/or nitroso-redox stress scavenger compound(s)
#414System and method for multi-parameter spectroscopy
#415Anti-EMAP II antibody and use thereof
#416NEW TAU SPECIES
#417Structure-based peptide inhibitors that target the Tau VQIINK fibrillization segment
#418Diagnostics Platform for Mitochondrial Dysfunctions/Diseases
#419Materials for preventing or treating Alzheimer's disease and compositions comprising same
#420EARLY DETECTION OF GLIAL CELL ACTIVATION IN NEURODEGENERATIVE OR NEUROINFLAMMATORY DISEASES
#421Conformational mimotopes for detecting specific antibodies
#422Functionalized eyewear device for detecting biomarker in tears
#423METHODS FOR QUANTIFYING SOLUBLE AMYLOID BETA AND AMYLOID BETA OLIGOMERS
#424Tau-binding antibodies
#425DIAGNOSTIC DRUG AND DIAGNOSTIC METHOD FOR ALZHEIMER'S DISEASE
#426Anti-tau antibodies and methods of use
#427Quantification of subpopulations of exosomes and diagnosis of neurogenerative disorders
#428Methods for ameliorating memory impairment in a memory disorder caused by neuronal cell death or Abeta aggregation using a peptide
#429Detection of Brain Injury or Neurological Disease using Tau Protein
#430Biomarkers of cognitive dysfunction
#431Γ-secretase stabilizing compound screening assay
#432USE OF APOE4 MOTIF-MEDIATED GENES FOR DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE
#433Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides
#434Peripheral diagnostic methods for screening Alzheimer's disease using beta amyloid and intercellular communication
#435Antibodies recognizing tau
#436Mutated tau protein fragment and use thereof
#437COMPOSITIONS AND METHODS RELATED TO K180 DIMETHYLATED H1.0 PROTEIN
#438Method for identifying inhibitors of primary nucleation of amyloid-beta aggregation
#439Antibody-based molecules specific for the truncated ASP421 epitope of Tau and their uses in the diagnosis and treatment of tauopathy
#440Molecularly-imprinted electrochemical sensors
#441Diagnostic autoantibody profiles for the detection and diagnosis of neurodegenerative diseases
#442Methods of diagnosing alzheimer's disease and risk of progression to alzheimer's disease
#443Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
#444COMBINED ASSAY FOR THE DIFFERENTIAL DIAGNOSIS OF THE ALZHEIMER'S DISEASE
#445Method for the preselection of drugs for protein misfolding diseases
#446Antibodies specific for hyperphosphorylated tau and methods of use thereof
#447Antibodies specific for hyperphosphorylated tau and methods of use thereof
#448Methods for detecting an individual as being at risk of developing a neurodegenerative disease
#449EVALUATING METHOD FOR MILD COGNITIVE IMPAIRMENT OR ALZHEIMER'S DISEASE
#450Assays to detect neurodegeneration
#451Alzheimer's disease assay in a living patient
#452Anti-PHF-tau antibodies and uses thereof
#453METHOD FOR DETERMINING ALZHEIMER'S DISEASE RISK
#454Compounds for imaging Tau protein aggregates
#455Compounds for imaging Tau protein aggregates
#456METHOD FOR ASSISTING DIAGNOSIS OF ALZHEIMER'S DISEASE USING URINE BIOMARKER
#457COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#458Diagnostic devices and methods of use
#459Blood Test for Screening Out Amyloid and Alzheimers Disease Presence
#460Methods and compositions for tauopathy diagnosis and treatment
#461Compositions and methods related to the methylation of histone H1.0 protein
#462Methods of identifying modulators of SAMTOR-GATOR1 interaction and use of same to modulate mTORC1
#463METHODS OF DIAGNOSIS ALZHEIMER'S DISEASE
#464Assay for diagnosing Alzheimer's disease
#465Protein Damage in Aging and Age-Related Diseases
#466Promer for Real-Time Detection of Nucleic Acid or Protein and Method of detecting Nucleic Acid or Protein Using the Same
#467Curcumin derivative, method for producing same, and photo-acoustic imaging agent comprising same for detecting beta-amyloid plaque
#468BLOOD-BASED SCREEN FOR DETECTING NEUROLOGICAL DISEASES IN PRIMARY CARE SETTINGS
#469Method for screening drug and therapeutic targets used for treating Alzheimer's disease
#470Conformation-independent antibodies against neurotoxic tau proteins
#471Methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders and associated processes
#472DIAGNOSTIC METHOD FOR MULTIPLE SCLEROSIS
#473CORTICAL NEURON CELL MODEL OF ALZHEIMER'S DISEASE BASED ON BMI1 DEFICIENCY, AND USES THEREOF
#474METHOD OF DISTINGUISHING BETWEEN DIFFERENT NEURODEGENERATIVE DISEASES
#475Antibody binding a linear epitope of human p53 and diagnostic applications thereof
#476ANTIBODY BASED REAGENT THAT SPECIFICALLY RECOGNIZES TOXIC OLIGOMERIC FORM OF BETA-AMYLOID
#477HIGH SENSITIVITY IMMUNOASSAYS AND KITS FOR THE DETERMINATION OF PEPTIDES AND PROTEINS OF BIOLOGICAL INTEREST
#478Diagnosing and treating Alzheimer's disease
#479Antibodies specific for hyperphosphorylated tau and methods of use thereof
#480Humanized tau antibodies in alzheimer's disease
#481SALIVARY ABETA42 LEVELS AS PROGNOSTIC INDICATORS FOR ALZHEIMER'S DISEASE
#482Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#483BIOMARKERS AND DIFFERENTIAL DIAGNOSIS OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS
#484METHODS FOR ESTIMATING MISFOLDED PROTEIN CONCENTRATION IN FLUIDS AND TISSUE BY QUANTITATIVE PMCA
#485NON-INVASIVE IMAGING METHOD FOR EARLY DETECTION AND MAPPING THE SEVERITY OF DISEASES BY USING CEST MRI
#486System and method for multi-parameter spectroscopy
#487Glucagon/GLP-1 receptor co-agonists
#488Method for detecting aggregate of aggregate-forming polypeptide
#489ASSAY FOR THE DIAGNOSIS OF A NEUROLOGICAL DISEASE
#490METHOD OF DETERMINING AUTOPHAGOSOME FLUX AND USES THEREOF
#491Combinatorial synthesis and biomarker development
#492Anti-Tau Antibodies and methods of use
#493Anti-Tau antibodies and methods of use
#494Rotaxane-type probe for molecular imaging
#495Tau protein-binding DNA aptamers with capture/detection and therapeutic utilities in tauopathy-related neurodegenerative disorders
#496DETECTION OF NEURODEGENERATIVE DISEASES
#497Use of an Anti-Alpha-Synuclein Antibody to Diagnose an Elevated Level of Alpha-Synuclein in the Brain
#498DIAGNOSTIC BIOMARKER PROFILES FOR THE DETECTION AND DIAGNOSIS OF ALZHEIMER'S DISEASE
#499Methods for measuring concentrations of biomolecules in biofluids
#500Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
#501Method for diagnosing alzheimer's disease using signal peptide as indicator
#502NEURONAL VIABILITY FACTOR AND USE THEREOF
#503Method and System for the Diagnosis, Prevention or Treatment of Alzheimer s and Related Disease by Measuring, Inhibiting or Arresting Amyloid Plaque Development
#504GLYCOPEPTIDES AND USES THEREOF
#505Amyloid β oligomer detection method, amyloid β oligomer detection device, and amyloid β oligomer detection program
#506EXOSOMAL TAU AS A BIOMARKER FOR BRAIN DISORDERS
#507DIAGNOSING MILD COGNITIVE IMPAIRMENT (MCI), PREDICTING ALZHEIMER'S DISEASE (AD) DEMENTIA ONSET, AND SCREENING AND MONITORING AGENTS FOR TREATING MCI OR PREVENTING DEMENTIA ONSET
#508Method for measuring phosphorylated tau protein
#509HUMANIZED ANTIBODY IGG1
#510Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy
#5113D-exoquant method for the analysis of surface molecules and quantification of tissue-specific exosomes in biological fluids
#512Optical method for the detection of Alzheimer's disease using curcumin
#513Specialized excitatory synaptic protein biomarkers of plasma neuronal exosomes for prediction and staging of Alzheimer's disease
#514HUMAN ALZHEIMER'S DISEASE AND TRAUMATIC BRAIN INJURY ASSOCIATED TAU VARIANTS AS BIOMARKERS AND METHODS OF USE THEREOF
#515Apparatus and method for cerebral microdialysis to treat neurological disease, including Alzheimer's, Parkinson's or multiple sclerosis
#516Blood-brain barrier permeable peptide compositions comprising a VAB domain of an anti-amyloid-beta camelid single-domain heavy-chain only antibody
#517Human anti-alpha-synuclein antibodies
#518SOLUBLE HIGH MOLECULAR WEIGHT (HMW) TAU SPECIES AND APPLICATIONS THEREOF
#519METHODS FOR EXTRACTING AND MEASURING CONCENTRATIONS OF BIOMOLECULES IN COMPLEX MATRICES WITHOUT THE NEED FOR IMMUNOCAPTURE
#520Reducing memory loss in mammals suffering from Alzheimer's disease
#521Method for detecting test substance and reagent kit for detecting test substance
#522Monomeric and Dimeric Forms of Adiponectin Receptor Fragments and Methods of Use
#523Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#524DETECTION OF BIOMARKERS ON VESICLES FOR THE DIAGNOSIS AND PROGNOSIS OF DISEASES AND DISORDERS
#525Diagnosis of a neurological disease
#526Detection of misfolded tau protein
#527Lactoferrin for use in the diagnosis or prognosis of Alzheimer's disease, or in the diagnosis of Parkinson's disease
#528HUMANIZED ANTIBODY
#529Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#530Antibody-based molecules selective for the Ser404 epitope of Tau and their uses in the diagnosis and treatment of tauopathy
#531System and method for multi-parameter spectroscopy
#532NOVEL LIGANDS FOR PREVENTION OF NEUROTOXICITY OF THE ALZHEIMER'S DISEASE RELATED AMYLOID-BETA PEPTIDE
#533ANTIBODY BASED REAGENTS THAT SPECIFICALLY RECOGNIZE TOXIC OLIGOMERIC FORMS OF TAU
#534Chimeric protein in the treatment of amyloidosis
#535Antibody array for measuring a panel of amyloids
#536NOVEL SLICE CULTURES AND METHODS FOR DIAGNOSING NEURONAL DEGENERATION DISEASES
#537METHOD FOR PREDICTING RISK OF COGNITIVE DETERIORATION
#538BIOMARKERS FOR PREDICTION, DIAGNOSIS, AND MONITORING OF ALZHEIMER'S DISEASE
#539Method of detecting an APP Alzheimer's disease marker peptide in patients with Alzheimer's disease
#540SRM METHODS IN ALZHEIMER'S DISEASE AND NEUROLOGICAL DISEASE ASSAYS
#541Lymphocyte-based morphometric test for alzheimer's disease
#542LYMPHOCYTE-BASED PKCe TEST FOR ALZHEIMER'S DISEASE
#543Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease
#544Synthetic blood vessels and uses thereof
#545COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#546DIAGNOSTIC TOOLS FOR ALZHEIMER'S DISEASE
#547DYES FOR ANALYSIS OF PROTEIN AGGREGATION
#548Liquid-liquid extraction methods for purifying and producing pure thioflavin T by monitoring light emission intensity of thioflavin T
#549METHOD OF IDENTIFYING BIOMARKERS OF NEUROLOGICAL DISEASES AND DIAGNOSIS OF NEUROLOGICAL DISEASES
#550DNA molecules encoding antibodies to tau and methods of making thereof
#551Anti-PHF-tau antibodies and uses thereof
#552Diagnosing and treating Alzheimers disease
#553Methods for providing information relevant to diagnosis of neurodegenerative disorder
#554Methods and probes for determining the concentration of copper
#555Methods for diagnosing and treating Alzheimers disease using G72 protein and SLC7A11 mRNA as biomarkers
#556Biomarkers and diagnostic methods for Alzheimer's disease and other neurodegenerative disorders
#557Method for monitoring post-translational modification of protein
#558Protein Damage in Aging and Age-Related Diseases
#559Method for treatment of traumatic brain injury targeting aggregated peptides
#560METHOD FOR DIAGNOSING EARLY ONSET OF ALZHEIMER'S DISEASE OR MILD COGNITIVE IMPAIRMENT
#561MODULAR CHEMIRESISTIVE SENSOR
#562DETECTION OF MISFOLDED PROTEINS
#563Detection of Misfolded Amyloid Beta Protein
#564Tau-binding antibodies
#565Methods for the treatment of neurological disorders
#566DIAGNOSTIC TEST FOR ALZHEIMER'S DISEASE BASED ON IDENTIFICATION OF A PROTEOLYTIC PATHWAY
#567Methods for the treatment and diagnosis of Alzheimer's disease and traumatic brain injuries
#568System and method for protein corona sensor array for early detection of diseases
#569FKBP52-TAU INTERACTION AS A NOVEL THERAPEUTICAL TARGET FOR TREATING THE NEUROLOGICAL DISORDERS INVOLVING TAU DYSFUNCTION
#570Metabolic biomarkers for memory loss
#571Antibody Therapy for Amyloid Beta Disease
#572Compositions, methods and kits for detection of genetic variants for alzheimer's disease
#573Antibodies to pyroglutamate amyloid-β and uses thereof
#574Humanized tau antibodies in a alzheimer's disease
#575Humanized antibodies
#576AGENT CONTAINING IMIDAZOLE DIPEPTIDE
#577BIOMOLECULES INVOLVED IN ALZHEIMER'S DISEASE
#578IN VITRO DIAGNOSTIC METHOD FOR ALZHEIMER'S DISEASE BASED ON THE ALBUMIN REDOX LEVEL IN THE CEREBROSPINAL FLUID
#579Method for determining the risk of developing alzheimer's disease
#580Alpha-Synuclein Antibodies (7A11)
#581Methods of treating Alzheimer's disease
#582Diagnostic markers of cognitive impairments, kits and uses thereof
#583BIOMARKER FOR PSYCHIATRIC AND NEUROLOGICAL DISORDERS
#584TREATMENT AND DIAGNOSTIC USING miRNA, PROTEIN AND GENE BIOMARKERS USING QUANTUM DOT FIELD-EFFECT TRANSISTOR (FET) SENSOR PLATFORM
#585Measuring GAPDH protein for diagnosis and treatment of alzheimer's disease
#586Making of organic nanobiomimetic memristor and memcapacitors and its applications in dual sensing of a biomarker in neurodegenerative diseases thereto
#587ANTIBODIES AGAINST MAMMAL SECRETED KLOTHO PROTEIN
#588BIOMARKERS AND DIAGNOSTIC METHODS FOR ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS
#589LABEL-FREE SINGLE AND MULTI-PHOTON FLUORESCENCE SPECTROSCOPY TO DETECT BRAIN DISORDERS AND DISEASE: ALZHEIMER, PARKINSON AND AUTISM FROM BRAIN TISSUE, CELLS, SPINAL FLUID AND BODY FLUIDS
#590Specific amyloid beta binding peptides and the use of same for treating and diagnosing alzheimer's dementia
#591Materials and methods for diagnosis and treatment of Alzheimer's disease
#592Method for assisting detection of alzheimer'S disease or mild cognitive impairment
#593DIAGNOSTIC METHOD
#594Monoclonal antibodies against amyloid beta protein and uses thereof
#595Methods of treating dementia associated with Alzheimer's disease with protective protein/cathepsin A (PPCA)
#596Antibody binding a linear epitope of human p53 and diagnostic applications thereof
#597A PEPTIDE OR COLLECTION OF PEPTIDES DERIVED FROM AMYLOID PRECURSOR PROTEIN
#598Antibody that recognises the T14 peptide of AChE
#599Anti-amyloid-beta antibodies
#600ANTIBODY HIGHLY SPECIFICALLY RECOGNIZING TURN STRUCTURE AT 22- AND 23-POSITIONS IN AMYLOID BETA